Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106.7 USD | -0.18% | +1.33% | -3.08% |
Apr. 23 | Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126 | MT |
Apr. 22 | Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating | MT |
Financials (USD)
Sales 2024 * | 41.7B | Sales 2025 * | 44.75B | Capitalization | 185B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.17B | EV / Sales 2024 * | 4.58 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 913M | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
31.2
x | P/E ratio 2025 * |
26.7
x | Employees | 114,000 |
Yield 2024 * |
2.03% | Yield 2025 * |
2.17% | Free-Float | 86.77% |
Latest transcript on Abbott Laboratories
1 day | -0.65% | ||
1 week | +0.93% | ||
Current month | -5.96% | ||
1 month | -3.33% | ||
3 months | -3.50% | ||
6 months | +12.74% | ||
Current year | -2.89% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +3.04% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 106.7 | -0.18% | 1 183 978 |
24-04-24 | 106.9 | -0.65% | 5,052,691 |
24-04-23 | 107.6 | +0.49% | 3,849,589 |
24-04-22 | 107.1 | -0.20% | 4,948,315 |
24-04-19 | 107.3 | +1.91% | 10,533,616 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.89% | 185B | |
-2.43% | 107B | |
-4.10% | 67.55B | |
+11.10% | 54.6B | |
+15.86% | 47.42B | |
+4.00% | 42.24B | |
+9.55% | 28.24B | |
+1.85% | 26.42B | |
+12.38% | 25.66B | |
-0.44% | 24.9B |
- Stock Market
- Equities
- ABT Stock